PACS Group (PACS) Q4 FY25 earnings call: guidance and Q&A

How does PACS's high quality ratings translate into payer conversations and potential share gain opportunities, particularly regarding cost-effectiveness in post-acute care?

Management stated that their model of acquiring facilities, deploying their operating model to improve quality, and achieving strong quality metrics makes them an attractive partner for insurers. This allows them to negotiate strong contracts, especially as facilities mature. They expect this trend to increase, leading to margin expansion as facilities move from lower to higher quality.

“As we go into these facilities upon acquisition, we deploy our operating model, which begins with providing high-quality care. And as you mentioned, we feel that as we move those facilities toward the quality metrics that we've been able to prove out through the new ramping and mature cohorts, we become a very attractive partner for really any of the insurers in the space that are looking for places to send their patients with high-quality care, access to bed, bed availability, density.”

asked by David MacDonald · answered by Joshua Jergensen

Can you provide more detail on the M&A pipeline, including the expected annual acquisition volume and the strategy for acquiring real estate alongside operations?

Management confirmed that 2026 guidance includes a nominal number of acquisitions (about 5 facilities per quarter) with minimal initial revenue and zero margin, as they typically acquire underperforming assets. The M&A pipeline is robust, and they remain strategic, seeking opportunities to acquire both real estate and operations to strengthen the balance sheet, while also partnering with capital providers as a high-quality operator and tenant.

“Pipeline, I would say, is very robust right now. We're starting to see a number of deals come through in very attractive areas as we continue to mature in the way that we evaluate deals. We feel really confident as we start to align the due diligence we're doing with deals that we're starting to see come up.”

asked by David MacDonald · answered by Joshua Jergensen

Given the success of the San Diego de novo, is there a chance for more frequent de novo activity in other states, considering the challenges in California?

Historically, de novo development has not been the primary growth driver due to acquisitions offering more attractive risk-adjusted returns and faster integration. While not opposed to it, de novo activity will likely remain selective, focusing on states and areas where it makes sense to add high-quality product. The short-term strategy will continue to be driven more by existing facility acquisitions.

“I think everyone can see that, historically, the de novo development hasn't been the primary driver of our growth strategies as acquisitions have generally offered more attractive risk-adjusted returns and faster integration into our platform, and that's what makes those incredibly attractive.”

asked by David MacDonald · answered by Joshua Jergensen

What are you observing regarding pricing in the M&A environment—is it softening or strengthening?

Pricing has increased in recent years due to inflation and rising real estate costs, which is reflected in lease costs and per-bed acquisition costs. While this trend continues in some markets, they are also seeing pricing start to plateau. The company remains selective and disciplined, only closing on a small fraction of potential deals that meet their investment profile.

“I mean we have seen price increases over recent years, right, with inflation and real estate prices going up and that being ultimately reflected in some of the leases that -- whether we acquire it via just operations or even the real estate cost per bed. And so we continue to see that in certain markets, but we also see that also starting to plateau in pricing versus, again, kind of the accelerated pricing we've seen in recent years.”

asked by David MacDonald · answered by Mark Hancock

What are your early observations on the impact of new staffing and infection prevention measures in the skilled nursing value-based purchasing program?

Management expressed confidence in their model, which prioritizes clinical quality, staffing to acuity, and staff education. They believe that tying reimbursement to quality metrics will be a net positive for PACS, as their strong clinical results and operational approach position them well to meet and exceed these new standards, unlike many others in the industry.

“Any time I think, as an organization, we see clinical quality tied to reimbursement, we feel very confident. Our model has always consistently began with care and the way that we provide our service to our patients, focusing on things like rehospitalization rates, focusing on staffing to acuity, educating our staff, training them, investing in the physical plans, which allows our facilities to be in a position to not only accept those patients, but do an excellent job taking care of them.”

asked by Benjamin Hendrix · answered by Joshua Jergensen

Is the TEAM model impacting your facilities or referral sources in your markets, and how is PACS positioned for it?

Management noted that these programs are in very early stages and are not new to the industry. They believe their platform's ability to be a top clinical provider, combined with bed density in communities, positions them as the primary provider of choice. This density allows for better access to beds and facilitates higher volumes for hospitalists and rounding physicians, improving care quality and access, making them well-positioned for TEAM and future programs.

“Very beginning stages of these programs, and I think each of you, obviously, been around the industry for a long time, know that a number of these have come up. This certainly is not the first. It won't be the last. Again, kind of back to the way that I answered the first part of the question, as there's an opportunity to identify ourselves as the top clinical provider in each of the communities that we're in, we believe that positions us in a great way to be the primary provider of choice.”

asked by Benjamin Hendrix · answered by Joshua Jergensen